BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6236946)

  • 1. [Antibacterial activity of a new synthetic penicillin: sodium sulbenicillin].
    Costa AL; Monforte MT; Cusumano V; Zamboni C
    Clin Ter; 1984 Jun; 109(6):557-61. PubMed ID: 6236946
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the minimal bactericidal time (MBT) of sulbenicillin against multiresistant pathogens.
    Debbia E; Pesce A; Schito GC
    Chemioterapia; 1987 Apr; 6(2):85-7. PubMed ID: 3647850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Restudies on antibacterial activity of sulbenicillin against anaerobic bacteria (author's transl)].
    Umemura A; Isono M; Yamada N; Kobayashi T; Watanabe K; Ueno K
    Jpn J Antibiot; 1981 Jun; 34(6):976-9. PubMed ID: 7026824
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibacterial activity in vitro of sulbenicillin against mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Eftimiadi C; De Leo C; Schito GC
    Drugs Exp Clin Res; 1985; 11(4):241-5. PubMed ID: 3939120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial activity of sulfobenzylpenicillin against anaerobic bacteria (author's transl)].
    Ueno K; Ninomiya K; Watanabe K; Murata K
    Jpn J Antibiot; 1979 Apr; 32(4):516-9. PubMed ID: 313459
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bactericidal and potent antiadhesive activity of sulbenicillin].
    Amato G; Nani E; Covelli B; Mattina R; Cocuzza G; Pappalardo C; Chisari G; Lo Bue AM; Gismondo MR; Nicoletti G
    G Batteriol Virol Immunol; 1986; 79(7-12):204-15. PubMed ID: 3135222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphology of Pseudomonas aeruginosa altered by antibiotic effect of sulbenicillin].
    Obana Y; Nakazawa S
    Nihon Saikingaku Zasshi; 1977 Mar; 32(2):337-43. PubMed ID: 406433
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative in vitro activities of SCE-129, sulbenicillin, gentamicin, and dibekacin against Pseudomonas.
    Tsuchiya K; Kondo M
    Antimicrob Agents Chemother; 1978 Mar; 13(3):536-9. PubMed ID: 122528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriological and clinical studies of sulbenicillin.
    Kjellander J; Lanner A; Norrby R
    Scand J Infect Dis; 1978; 10(3):235-41. PubMed ID: 362518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on 6 alpha-substituted penicillins. II. Synthesis and structure-activity relationships of 6 beta-(2-aryl-2-sulfoacetamido)-6 alpha-methoxy penicillanic acids.
    Burton G; Best DJ; Dixon RA; Kenyon RF; Lashford AG
    J Antibiot (Tokyo); 1986 Oct; 39(10):1419-29. PubMed ID: 3096924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Various characteristics of Pseudomonas elongated by the action of synthetic penicillins].
    Obana Y; Kuroda H; Nakazawa S
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):108. PubMed ID: 814341
    [No Abstract]   [Full Text] [Related]  

  • 12. [Investigations on antibacterial activity of apalcillin].
    Stille W; Helm E; Mielenz H
    Arzneimittelforschung; 1982; 32(9):1128-30. PubMed ID: 6816250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic control of sulbenicillin (SBPC)-induced T cell proliferation in mice.
    Ikezawa Z; Kawaguchi H; Sato M
    J Dermatol; 1986 Feb; 13(1):38-44. PubMed ID: 3522692
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of the antibacterial activity of water and ether extracts of fosfomycin and azidocillin].
    Pase U; Fusetti F; Nicolin T
    G Stomatol Ortognatodonzia; 1983; 2(2):57-9. PubMed ID: 6441786
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of platelet function by sulbenicillin and its metabolite.
    Ikeda Y; Kikuchi M; Matsuda S; Toyama K; Hasegawa M; Watanabe K; Ando Y
    Antimicrob Agents Chemother; 1978 May; 13(5):881-3. PubMed ID: 666307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free-Wilson analysis of the antibacterial activity of fluoronaphthyridines against various microbes. A new application of indicator variables.
    Terada Y; Nanya K
    Pharmazie; 2000 Feb; 55(2):133-5. PubMed ID: 10723773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of intravitreal injection of sulfobenzylpenicillin on the ERG and the VEP].
    Kawasaki K; Mochizuki K; Yonemura D; Ohnogi J; Okayama Y
    Nippon Ganka Gakkai Zasshi; 1985 Dec; 89(12):1334-9. PubMed ID: 3832904
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of intravitreal injection of sulfobenzylpenicillin on the ERG].
    Mochizuki K; Torisaki M; Kawasaki K; Yonemura D
    Nippon Ganka Gakkai Zasshi; 1986 Oct; 90(10):1211-6. PubMed ID: 3799376
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxazolidinones: new antibacterial agents.
    Ford CW; Hamel JC; Stapert D; Moerman JK; Hutchinson DK; Barbachyn MR; Zurenko GE
    Trends Microbiol; 1997 May; 5(5):196-200. PubMed ID: 9160508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vivo activities of cefsulodin, sulbenicillin, and gentamicin against Pseudomonas aeruginosa.
    Kondo M; Tsuchiya K
    Antimicrob Agents Chemother; 1978 Jul; 14(1):151-3. PubMed ID: 249623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.